These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2877883)
1. Pharmacokinetics of single and multiple doses of flusoxolol (Ro 31-1411) in healthy subjects. Gillies HC; Rogers HJ; Francis RJ; Galloway DB; Humphreys JE Eur J Clin Pharmacol; 1986; 31(1):113-5. PubMed ID: 2877883 [TBL] [Abstract][Full Text] [Related]
2. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man. McCaffrey PM; Riddell JG; Shanks RG Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634 [TBL] [Abstract][Full Text] [Related]
3. Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives. Jamieson M; Petrie JC; Webster J; Miller A; Harris RI; Francis RJ Eur J Clin Pharmacol; 1985; 29(4):395-9. PubMed ID: 2868899 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers. Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration. Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538 [TBL] [Abstract][Full Text] [Related]
8. Comparative single dose and steady-state pharmacokinetics of bevantolol in young and elderly subjects. Selen A; Kinkel AW; Darke AC; Greene DS; Welling PG Eur J Clin Pharmacol; 1986; 30(6):699-704. PubMed ID: 2876899 [TBL] [Abstract][Full Text] [Related]
9. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist. O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of dl- and l-moprolol in the human. Harvengt C; Desager JP Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):57-61. PubMed ID: 6120901 [TBL] [Abstract][Full Text] [Related]
11. Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist. Leopold G; Pabst J; Ungethüm W; Bühring KU J Clin Pharmacol; 1986; 26(8):616-21. PubMed ID: 2878941 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of nadolol, a beta-receptor antagonist: administration of therapeutic single- and multiple-dosage regimens to hypertensive patients. Dreyfuss J; Griffith DL; Singhvi SM; Shaw JM; Ross JJ; Vukovich RA; Willard DA J Clin Pharmacol; 1979; 19(11-12):712-20. PubMed ID: 43870 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings]. Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Morselli PL; Thébault JJ; Trocherie S Br J Clin Pharmacol; 1979 Oct; 8(4):408P. PubMed ID: 41560 [No Abstract] [Full Text] [Related]
14. Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay. Wellstein A; Palm D; Belz GG; Leopold G; Bühring KU; Pabst J J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S41-5. PubMed ID: 2439797 [TBL] [Abstract][Full Text] [Related]
16. [Comparative pharmacokinetics of the beta-1 receptor blookader celiprolol after a single oral administration in subjects with health kidneys and in patients with impaired renal function]. Schmidt P; Takacs F; Pittner H; Minar E; Balcke P; Zazgornik J; Deutsch E Wien Klin Wochenschr; 1985 Sep; 97(18):729-32. PubMed ID: 2866633 [TBL] [Abstract][Full Text] [Related]
17. Esmolol: a pharmacokinetic profile of a new cardioselective beta-blocking agent. Yacobi A; Kartzinel R; Lai CM; Sum CY J Pharm Sci; 1983 Jun; 72(6):710-1. PubMed ID: 6135794 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol. Regårdh CG Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402 [No Abstract] [Full Text] [Related]
19. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration. Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139 [TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man. Morita S; Iinuma M; Kido M; Sakuragi S; Kohri H; Nishino H Arzneimittelforschung; 1977; 27(12):2380-3. PubMed ID: 23800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]